Form N-2/A - Registration statement for closed-end investment companies: [Amend]
SEC Accession No. 0001193125-22-113017
Filing Date
2022-04-21
Accepted
2022-04-21 16:16:40
Documents
8

Document Format Files

Seq Description Document Type Size
1 BLACKROCK HEALTH SCIENCES TRUST d269284dn2a.htm N-2/A 1807917
2 OPINION AND CONSENT OF COUNSEL TO THE REGISTRANT d269284dex99l.htm EX-99.(L) 15066
3 INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM CONSENT d269284dex99n.htm EX-99.(N) 2477
4 EX-FILING FEES d269284dexfilingfees.htm EX-FILING FEES 39712
6 GRAPHIC g269284g0419134632888.jpg GRAPHIC 4176
7 GRAPHIC g269284g21a07.jpg GRAPHIC 56275
8 GRAPHIC g269284g28z86.jpg GRAPHIC 6995
9 GRAPHIC g269284g64k79.jpg GRAPHIC 63350
  Complete submission text file 0001193125-22-113017.txt   2047352
Mailing Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809
Business Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809 (888) 825-2257
BlackRock Health Sciences Trust (Filer) CIK: 0001314966 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: N-2/A | Act: 40 | File No.: 811-21702 | Film No.: 22841624

Mailing Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809
Business Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809 (888) 825-2257
BlackRock Health Sciences Trust (Filer) CIK: 0001314966 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: N-2/A | Act: 33 | File No.: 333-263527 | Film No.: 22841623